מדינה: קנדה
שפה: אנגלית
מקור: Health Canada
TRETINOIN
BAUSCH HEALTH, CANADA INC.
D10AD01
TRETINOIN
0.05%
LOTION
TRETINOIN 0.05%
TOPICAL
100
Prescription
CELL STIMULANTS AND PROLIFERANTS
Active ingredient group (AIG) number: 0112395001; AHFS:
APPROVED
2021-10-08
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR ALTRENO TM Tretinoin Lotion Lotion with moisturizers 0.05% w/w COMEDOLYTIC AGENT BAUSCH HEALTH, CANADA INC. 2150 St-Elzear Blvd., West Laval, Quebec H7L 4A8 Canada DATE OF REVISION: October 7, 2021 Submission Control No: 251922 _ _ _Pr_ _ALTRENO_ _TM_ _ – Product Monograph Page 2 of 28_ TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED. TABLE OF CONTENTS .......................................................................................................... 2 PART I: HEALTH PROFESSIONAL INFORMATION............................................................... 4 1 INDICATIONS.............................................................................................................. 4 1.1 Pediatrics ........................................................................................................... 4 1.2 Geriatrics............................................................................................................ 4 2 CONTRAINDICATIONS ............................................................................................... 4 4 DOSAGE AND ADMINISTRATION .............................................................................. 4 4.2 Recommended Dose and Dosage Adjustment .................................................... 4 4.4 Administration..................................................................................................... 5 5 OVERDOSAGE ........................................................................................................... 5 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING ........................ 6 7 WARNINGS AND PRECAUTIONS .............................................................................. 6 7.1 Special Populations ............................................................................................ 7 7.1.1 Pregnant Women ............................................................................... קרא את המסמך השלם